Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes

Alison Hamilton; Gerald W Zamponi; Stephen S G Ferguson

doi:10.1186/s13041-015-0107-0

journal article Open Access Mar 24, 2015

Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes

Alison Hamilton Gerald W Zamponi Stephen S G Ferguson

Molecular Brain Vol. 8 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/s13041-015-0107-0

Topics

No keywords indexed for this article. Browse by subject →

References

109

[1]

Association A. Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2013;2013(9):208–45. 10.1016/j.jalz.2013.02.003

[2]

Dubois B, Feldman H, Jacova C, Hampel H, Molinuevo J, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29. 10.1016/s1474-4422(14)70090-0

[3]

Alzheimer A. Ueber eine eigenartige Erkrankung der Hirnrinde. Zeitschrift fuer Psychiatr. 1907;64:146–9.

[4]

Alzheimer A, Stelzmann RA, Schnitzlen HN, Murthagh FR. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat. 1995;8:429–31. 10.1002/ca.980080612

[5]

Braak E, Braak H. Alzheimer’s disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn. Acta Neuropathol. 1997;93:323–5. 10.1007/s004010050622

[6]

Glass C, Saijo K, Winner B, Marchetto M, Gage F. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918–34. 10.1016/j.cell.2010.02.016

[7]

Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review: Alzheimer’s amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol. 2000;130:184–208. 10.1006/jsbi.2000.4274

[8]

Guglielmotto M, Giliberto L, Tamagno E, Tabaton M. Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors. Front Aging Neurosci. 2010;2(February):3.

[9]

Selkoe DJ. Toward a comprehensive theory for Alzheimer’s disease. Hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci. 2000;924:17–25. 10.1111/j.1749-6632.2000.tb05554.x

[10]

Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein

Ji Won Um, Adam C. Kaufman, Mikhail Kostylev et al.

Neuron 2013 10.1016/j.neuron.2013.06.036

[11]

APP processing in Alzheimer's disease

ROBERT THOMPSON, Han Zhang, Huaxi Xu

Molecular Brain 2011 10.1186/1756-6606-4-3

[12]

Hamilton A, Esseltine JL, DeVries RA, Cregan SP, Ferguson SSG. Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer’s disease. Mol Brain. 2014;7:40. 10.1186/1756-6606-7-40

[13]

Selkoe DJ. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer’s disease. Trends Cell Biol. 1998;8:447–53. 10.1016/s0962-8924(98)01363-4

[14]

Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective

Rudolph E. Tanzi, Lars Bertram

Cell 2005 10.1016/j.cell.2005.02.008

[15]

Chow VW, Mattson MP, Wong PC, Gleichmann M. An overview of APP processing enzymes and products. Neuromolecular Med. 2010;12:1–12. 10.1007/s12017-009-8104-z

[16]

Ma H, Lesné S, Kotilinek L, Steidl-Nichols JV, Sherman M, Younkin L, et al. Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc Natl Acad Sci U S A. 2007;104:8167–72. 10.1073/pnas.0609521104

[17]

Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP Processing and Synaptic Function State University of New York at Stony Brook. Neuron. 2003;37:925–37. 10.1016/s0896-6273(03)00124-7

[18]

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Christian Haass, Dennis J. Selkoe

Nature Reviews Molecular Cell Biology 2007 10.1038/nrm2101

[19]

Citron M, Diehl TS, Gordon G, Biere AL, Seubert P, Selkoe DJ. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc Natl Acad Sci U S A. 1996;93:13170–5. 10.1073/pnas.93.23.13170

[20]

Gordon MN, King DL, Diamond DM, Jantzen PT, Boyett KV, Hope CE, et al. Correlation between cognitive deficits and Abeta deposits in transgenic APP + PS1 mice. Neurobiol Aging. 2001;22:377–85. 10.1016/s0197-4580(00)00249-9

[21]

McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2006;47:191–9. 10.1016/j.neuron.2005.06.030

[22]

Lesne S, Koh M, Kotilinek L, Kayed R, Glabe C, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440:352–7. 10.1038/nature04533

[23]

Gong Y, Chang L, Viola K, Lacor P, Lambert M, Finch C, et al. Alzheimer’s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A. 2003;100:10417–22. 10.1073/pnas.1834302100

[24]

Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, et al. Synaptic targeting by Alzheimer’s-related amyloid beta oligomers. J Neurosci. 2004;24:10191–200. 10.1523/jneurosci.3432-04.2004

[25]

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers

Juha Laurén, David A. Gimbel, Haakon B. Nygaard et al.

Nature 2009 10.1038/nature07761

[26]

De Felice FG, Vieira MNN, Bomfim TR, Decker H, Velasco PT, Lambert MP, et al. Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A. 2009;106:1971–6. 10.1073/pnas.0809158106

[27]

Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5

Marianne Renner, Pascale N. Lacor, Pauline T. Velasco et al.

Neuron 2010 10.1016/j.neuron.2010.04.029

[28]

Beraldo FH, Arantes CP, Santos TG, Machado CF, Roffe M, Hajj GN, et al. Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain. FASEB J. 2011;25:265–79. 10.1096/fj.10-161653

[29]

The prion protein as a receptor for amyloid-β

Helmut W. Kessels, Louis N. Nguyen, Sadegh Nabavi et al.

Nature 2010 10.1038/nature09217

[30]

Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev. 2008;88:673–728. 10.1152/physrev.00007.2007

[31]

Albasanz JL, Dalfó E, Ferrer I, Martín M. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer’s disease and dementia with Lewy bodies correlates with stage of Alzheimer’s-disease-related changes. Neurobiol Dis. 2005;20:685–93. 10.1016/j.nbd.2005.05.001

[32]

Piani D, Frei K, Do K, Cuenod M, Fontana A. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci let. 1991;133:159–62. 10.1016/0304-3940(91)90559-c

[33]

Piani D, Spranger M, Frei K, Schaffner A, Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol. 1992;9:2429–36. 10.1002/eji.1830220936

[34]

Rao V, Bowen K, Dempsey R. Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. Neurochem Res. 2001;26:497–502. 10.1023/a:1010956711295

[35]

Ribeiro FM, Paquet M, Cregan SP, Ferguson SSG. Group 1 metabotropic glutamate receptor signaling and its implication in neurological disease. CNS Neurol Discord Drug Targets. 2010;9:574–95. 10.2174/187152710793361612

[36]

Balazs R, Miller S, Romano C, de Vries A, Chun Y, Cotman CW. Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation. J Neurochem. 1997;69:151–63. 10.1046/j.1471-4159.1997.69010151.x

[37]

Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;8:623–34. 10.1016/0896-6273(88)90162-6

[38]

Dhami GK, Ferguson SSG. Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis. Pharmacol Ther. 2006;111:260–71. 10.1016/j.pharmthera.2005.01.008

[39]

Bordi F, Ugolini A. Group 1 metabotropic glutamate receptors: implications for brain diseases. Prog Neurobiol. 1999;59:55–79. 10.1016/s0301-0082(98)00095-1

[40]

Bruno V, Battaglia G, Copani A, Cespédes VM, Galindo MF, Ceña V, et al. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eur J Neurosci. 2001;13:1469–78. 10.1046/j.0953-816x.2001.01541.x

[41]

Opitz T, Reymann K. (1S, 3R)-ACPD protects synaptic transmission from hypoxia in hippocampal slices. Neuropharmacology. 1993;32:103–4. 10.1016/0028-3908(93)90136-q

[42]

Choe ES, Wang JQ. Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum. Neurosci Lett. 2001;313:129–32. 10.1016/s0304-3940(01)02258-3

[43]

Nicodemo AA, Pampillo M, Ferreira LT, Dale LB, Cregan T, Ribeiro FM, et al. Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1/2 activation. Mol Brain. 2010;3:4. 10.1186/1756-6606-3-4

[44]

Hou L, Klann E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci. 2004;24:6352–61. 10.1523/jneurosci.0995-04.2004

[45]

Mao L, Yang L, Tang Q, Samdani S, Zhang G, Wang JQ. The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J Neurosci. 2005;25:2741–52. 10.1523/jneurosci.4360-04.2005

[46]

Rong R, Ahn J-Y, Huang H, Nagata E, Kalman D, Kapp JA, et al. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat Neurosci. 2003;6:1153–61. 10.1038/nn1134

[47]

Wu J, Rush A, Rowan MJ, Anwyl R. NMDA receptor and metabotropic glutamate receptor-dependent synaptic plasticity induced by high frequency stimulation in the rat dentate gyrus in vitro. J Physiol. 2001;533:745–55. 10.1111/j.1469-7793.2001.t01-1-00745.x

[48]

Doherty AJ, Palmer MJ, Henley JM, Collingridge GL, Jane DE. Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5 but not mGlu1 receptors expressed in CHO cells and potentiates NMDAA responses in the hippocampus. Neuropharmacology. 1997;36:265–7. 10.1016/s0028-3908(97)00001-4

[49]

Alagarsamy S, Saugstad J, Warren L, Mansuy IM, Gereau RWI, Conn PJ. NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin. Neuropharmacology. 2005;49:135–45. 10.1016/j.neuropharm.2005.05.005

[50]

Ribeiro FM, Paquet M, Ferreira LT, Cregan T, Swan P, Cregan SP, et al. Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington’s disease. J Neurosci. 2010;30:316–24. 10.1523/jneurosci.4974-09.2010

Showing 50 of 109 references

Metrics

62

Citations

109

References

Details

Published: Mar 24, 2015
Vol/Issue: 8(1)
License: View

Authors

Cite This Article

Alison Hamilton, Gerald W Zamponi, Stephen S G Ferguson (2015). Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes. Molecular Brain, 8(1). https://doi.org/10.1186/s13041-015-0107-0

Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes

You May Also Like